We are live on ! Find out more
SR

Summer Road Portfolio holdings

AUM $161M
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
-18.79%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$23.9M
AUM Growth
-$5.53M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
17 quarters
Top 10 Avg Time Held
17 quarters
Top 20 Avg Time Held
17 quarters

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
OCUL icon
1
Ocular Therapeutix
OCUL
$1.53B
$23.9M 100%
5,944,761
– –
2018 Q1
17 quarters

Similar funds

Summer Road's Q2 2022 Portfolio in Review

As of Q2 2022, Summer Road held 1 position worth $23.9M, down 19% from $29.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Summer Road opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Summer Road's ten largest holdings make up 100% of its $23.9M portfolio in Q2 2022.
  • Summer Road opened 0 new positions and closed 0 in Q2 2022.
  • Summer Road's portfolio value fell 19% quarter-over-quarter to $23.9M.

Based on Summer Road's 13F filing for Q2 2022, filed 15 Aug 2022.